ET
CVS icon

Equitable Trust’s CVS Health CVS Stock Holding History

Equitable Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,885
Closed -$1.5M – 473
2024
Q3 		$1.5M Sell
23,885
-5,158
-18% -$301K 0.1% 158
2024
Q2 		$1.72M Sell
29,043
-5,213
-15% -$326K 0.12% 144
2024
Q1 		$2.73M Buy
34,256
+6,974
+26% +$533K 0.19% 107
2023
Q4 		$2.15M Buy
27,282
+11,128
+69% +$792K 0.16% 117
2023
Q3 		$1.13M Buy
16,154
+6,917
+75% +$490K 0.09% 153
2023
Q2 		$639K Hold
9,237
– – 0.05% 226
2023
Q1 		$686K Buy
9,237
+2,345
+34% +$197K 0.05% 213
2022
Q4 		$642K Hold
6,892
– – 0.05% 228
2022
Q3 		$657K Sell
6,892
-148
-2% -$14.7K 0.05% 213
2022
Q2 		$653K Sell
7,040
-74
-1% -$7.22K 0.05% 222
2022
Q1 		$720K Buy
7,114
+186
+3% +$19.5K 0.05% 205
2021
Q4 		$715K Sell
6,928
-867
-11% -$80.1K 0.04% 204
2021
Q3 		$662K Buy
7,795
+312
+4% +$26.1K 0.04% 213
2021
Q2 		$625K Buy
7,483
+179
+2% +$14.7K 0.04% 225
2021
Q1 		$550K Buy
7,304
+1,651
+29% +$120K 0.04% 235
2020
Q4 		$386K Buy
5,653
+1,900
+51% +$124K 0.03% 266
2020
Q3 		$219K Sell
3,753
-70
-2% -$4.36K 0.02% 302
2020
Q2 		$249K Sell
3,823
-695
-15% -$43.8K 0.02% 285
2020
Q1 		$268K Sell
4,518
-805
-15% -$53.7K 0.03% 267
2019
Q4 		$395K Sell
5,323
-748
-12% -$52.5K 0.04% 218
2019
Q3 		$383K Sell
6,071
-183
-3% -$10.8K 0.04% 210
2019
Q2 		$341K Buy
6,254
+261
+4% +$14.1K 0.04% 222
2019
Q1 		$323K Sell
5,993
-17,407
-74% -$1.07M 0.04% 231
2018
Q4 		$1.53M Buy
23,400
+18,621
+390% +$1.39M 0.2% 112
2018
Q3 		$377K Sell
4,779
-5,861
-55% -$419K 0.04% 226
2018
Q2 		$685K Buy
+10,640
New +$701K 0.09% 165

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Equitable Trust's CVS Position: Q4 2024 in Review

Equitable Trust sold out of CVS Health (CVS) in Q4 2024, closing a stake of 23,885 shares — an estimated $1.5M sold.

Equitable Trust first reported a position in CVS in Q2 2018 and held it in 26 quarters. The position peaked at $2.73M in Q1 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Equitable Trust reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Equitable Trust sold 23,885 CVS Health shares in Q4 2024, an estimated $1.5M.
  • Equitable Trust first reported a position in CVS Health in Q2 2018 and held it in 26 quarters.
  • Equitable Trust's CVS Health position peaked at $2.73M in Q1 2024.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Equitable Trust's 13F filing for Q4 2024, filed 28 Jan 2025.